Equities Research Analysts’ price target changes for Friday, October 6th:

Agilent Technologies (NYSE:A) had its price target boosted by Morgan Stanley from $76.00 to $86.00. The firm currently has an overweight rating on the stock.

Align Technology (NASDAQ:ALGN) had its target price boosted by Morgan Stanley from $195.00 to $220.00. They currently have an overweight rating on the stock.

Amgen (NASDAQ:AMGN) had its target price raised by Morgan Stanley from $189.00 to $196.00. They currently have an overweight rating on the stock.

ASML Holding (AMS:AMSL) was given a €166.00 ($195.29) target price by analysts at Morgan Stanley. The firm currently has a buy rating on the stock.

Bayer AG (FRA:BAYN) was given a €124.00 ($145.88) price target by analysts at Commerzbank Ag. The firm currently has a buy rating on the stock.

BeiGene (NASDAQ:BGNE) had its target price raised by Morgan Stanley from $87.00 to $95.00. Morgan Stanley currently has an overweight rating on the stock.

Bioverativ (NASDAQ:BIVV) had its price target boosted by Morgan Stanley from $45.00 to $47.00. Morgan Stanley currently has an underweight rating on the stock.

BioMarin Pharmaceutical (NASDAQ:BMRN) had its target price boosted by Morgan Stanley from $115.00 to $117.00. The firm currently has an overweight rating on the stock.

Cummins (NYSE:CMI) had its target price boosted by Wells Fargo & Company from $184.50 to $190.00. Wells Fargo & Company currently has a market perform rating on the stock.

Coach (NYSE:COH) had its price target reduced by Buckingham Research from $56.00 to $48.00. They currently have a buy rating on the stock.

Cytokinetics, (NASDAQ:CYTK) had its target price increased by Morgan Stanley from $24.00 to $25.00. They currently have an overweight rating on the stock.

Daimler AG (ETR:DAI) was given a €66.00 ($77.65) price target by analysts at Nord/LB. The firm currently has a neutral rating on the stock.

DBV Technologies (NASDAQ:DBVT) had its target price boosted by Morgan Stanley from $70.00 to $72.00. Morgan Stanley currently has an overweight rating on the stock.

D.R. Horton (NYSE:DHI) had its price target increased by Bank of America Corporation from $43.00 to $55.00. They currently have a buy rating on the stock.

Danaher Corporation (NYSE:DHR) had its target price increased by Morgan Stanley from $86.00 to $95.00. Morgan Stanley currently has an overweight rating on the stock.

Editas Medicine (NASDAQ:EDIT) had its price target boosted by Morgan Stanley from $27.00 to $28.00. The firm currently has an equal weight rating on the stock.

Equifax (NYSE:EFX) was given a $127.00 target price by analysts at Wells Fargo & Company. The firm currently has a buy rating on the stock.

easyJet plc (LON:EZJ) was given a GBX 1,600 ($21.22) price target by analysts at Sanford C. Bernstein. The firm currently has a buy rating on the stock.

Fifth Third Bancorp (NASDAQ:FITB) had its target price boosted by UBS AG from $25.00 to $26.00. The firm currently has a sell rating on the stock.

Fraport AG Frankfurt Arprt Svcs Wrldwde (FRA:FRA) was given a €105.00 ($123.53) price target by analysts at Kepler Capital Markets. The firm currently has a buy rating on the stock.

Global Blood Therapeutics (NASDAQ:GBT) had its price target raised by Morgan Stanley from $51.00 to $56.00. They currently have an overweight rating on the stock.

Gilead Sciences (NASDAQ:GILD) had its target price raised by Morgan Stanley from $77.00 to $83.00. The firm currently has an equal weight rating on the stock.

Galapagos NV (NASDAQ:GLPG) had its target price boosted by Morgan Stanley from $92.00 to $123.00. The firm currently has an overweight rating on the stock.

Haemonetics Corporation (NYSE:HAE) had its target price increased by Morgan Stanley from $38.00 to $43.00. They currently have an equal weight rating on the stock.

HD Supply Holdings (NASDAQ:HDS) had its target price increased by Wells Fargo & Company from $40.00 to $42.00. Wells Fargo & Company currently has an outperform rating on the stock.

Iberdrola SA (MCE:IBE) was given a €6.70 ($7.88) target price by analysts at Credit Suisse Group AG. The firm currently has a neutral rating on the stock.

Innoviva (NASDAQ:INVA) had its target price raised by Morgan Stanley from $7.00 to $8.00. The firm currently has an underweight rating on the stock.

J P Morgan Chase & Co (NYSE:JPM) had its target price raised by Citigroup Inc. from $90.00 to $96.00. They currently have a neutral rating on the stock.

Juno Therapeutics (NASDAQ:JUNO) had its target price increased by Morgan Stanley from $27.00 to $43.00. They currently have an equal weight rating on the stock.

Michael Kors Holdings Limited (NYSE:KORS) had its target price raised by Buckingham Research from $46.00 to $52.00. They currently have a neutral rating on the stock.

Lennox International (NYSE:LII) had its price target raised by Wells Fargo & Company from $190.00 to $193.00. The firm currently has a market perform rating on the stock.

Loxo Oncology (NASDAQ:LOXO) had its target price raised by Morgan Stanley from $95.00 to $103.00. Morgan Stanley currently has an overweight rating on the stock.

Moody’s Corporation (NYSE:MCO) had its price target raised by Morgan Stanley from $134.00 to $135.00. Morgan Stanley currently has an equal weight rating on the stock.

MGM Resorts International (NYSE:MGM) was given a $35.00 price target by analysts at Morgan Stanley. The firm currently has a buy rating on the stock.

Mettler-Toledo International (NYSE:MTD) had its price target cut by Morgan Stanley from $565.00 to $535.00. The firm currently has an equal weight rating on the stock.

MTU Aero Engines AG (ETR:MTX) was given a €145.00 ($170.59) price target by analysts at Kepler Capital Markets. The firm currently has a buy rating on the stock.

Myriad Genetics (NASDAQ:MYGN) had its price target increased by Morgan Stanley from $17.00 to $24.00. The firm currently has an underweight rating on the stock.

Mylan N.V. (NASDAQ:MYL) had its target price raised by Morgan Stanley from $36.00 to $39.00. They currently have an equal weight rating on the stock.

Navistar International Corporation (NYSE:NAV) had its target price increased by Wells Fargo & Company from $41.00 to $45.00. Wells Fargo & Company currently has a market perform rating on the stock.

Natera (NASDAQ:NTRA) had its price target raised by Morgan Stanley from $13.00 to $16.00. They currently have an overweight rating on the stock.

NuVasive (NASDAQ:NUVA) had its price target cut by Morgan Stanley from $81.00 to $70.00. Morgan Stanley currently has an equal weight rating on the stock.

PACCAR (NASDAQ:PCAR) had its target price increased by Wells Fargo & Company from $74.00 to $77.00. The firm currently has a market perform rating on the stock.

Parker-Hannifin Corporation (NYSE:PH) had its target price raised by Wells Fargo & Company from $181.50 to $196.00. Wells Fargo & Company currently has a market perform rating on the stock.

PerkinElmer (NYSE:PKI) had its price target cut by Morgan Stanley from $79.00 to $77.00. They currently have an overweight rating on the stock.

Portola Pharmaceuticals (NASDAQ:PTLA) had its price target raised by Morgan Stanley from $75.00 to $81.00. They currently have an overweight rating on the stock.

PayPal Holdings (NASDAQ:PYPL) had its target price boosted by Bank of America Corporation from $71.00 to $78.00. They currently have a buy rating on the stock.

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target increased by Morgan Stanley from $69.00 to $71.00. The firm currently has an equal weight rating on the stock.

Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target boosted by Morgan Stanley from $450.00 to $490.00. Morgan Stanley currently has an equal weight rating on the stock.

Roche Holding (VTX:ROG) was given a CHF 260 target price by analysts at Morgan Stanley. The firm currently has a neutral rating on the stock.

Sanofi SA (EPA:SAN) was given a €92.00 ($108.24) target price by analysts at Morgan Stanley. The firm currently has a buy rating on the stock.

SAP SE (ETR:SAP) was given a €93.00 ($109.41) price target by analysts at UBS AG. The firm currently has a neutral rating on the stock.

Siemens AG (FRA:SIE) was given a €120.00 ($141.18) target price by analysts at Barclays PLC. The firm currently has a neutral rating on the stock.

S&P Global (NYSE:SPGI) had its target price boosted by Morgan Stanley from $154.00 to $158.00. They currently have an equal weight rating on the stock.

SunTrust Banks (NYSE:STI) had its target price raised by UBS AG from $61.00 to $62.00. They currently have a neutral rating on the stock.

STMicroelectronics NV (EPA:STM) was given a €11.70 ($13.76) price target by analysts at Morgan Stanley. The firm currently has a sell rating on the stock.

Constellation Brands (NYSE:STZ) had its target price boosted by Morgan Stanley from $218.00 to $245.00. The firm currently has an overweight rating on the stock.

Universal Logistics Holdings (NYSE:ULH) had its target price increased by Citigroup Inc. from $14.00 to $22.00. They currently have a neutral rating on the stock.

Waters Corporation (NYSE:WAT) had its target price raised by Morgan Stanley from $183.00 to $192.00. The firm currently has an underweight rating on the stock.

WESCO International (NYSE:WCC) had its price target boosted by Wells Fargo & Company from $65.00 to $67.00. The firm currently has an outperform rating on the stock.

Wacker Chemie AG (ETR:WCH) was given a €118.00 ($138.82) price target by analysts at Independent Research GmbH. The firm currently has a neutral rating on the stock.

Wells Fargo & (NYSE:WFC) was given a $57.00 target price by analysts at UBS AG. The firm currently has a hold rating on the stock.

Xenia Hotels & Resorts (NYSE:XHR) had its price target boosted by Wells Fargo & Company from $19.50 to $20.00. The firm currently has an outperform rating on the stock.

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price raised by Morgan Stanley from $67.00 to $69.00. They currently have an overweight rating on the stock.

Yum! Brands (NYSE:YUM) had its price target boosted by Bank of America Corporation from $41.60 to $45.10. The firm currently has a neutral rating on the stock.

Receive News & Ratings for Agilent Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.